Research Support - Institute of Pharmacology

Current research support

Targeting Cellular Interfaces in Reperfused Myocardial Infarction (supported by the DFG Research Training Group 2989, Project No. 517043330): 2024-2029

FKBP5 and cardiac arrhythmogenesis (supported by the National Institutes of Health, collaborative project with Baylor College of Medicine, Houston, TX, USA, Proposal No 1R01HL164838-01A1): 2023-2028

Resolution of Inflammation and Atrial Fibrillation (supported by the National Institutes of Health, collaborative project with University of Minnesota, Minneapolis, MN, USA, Proposal No 1R01HL165704-01A1): 2023-2028

Role of Nucleoside-Diphosphate Kinase signaling in atrial fibrillation (supported by the National Institutes of Health, collaborative project with Baylor College of Medicine, Houston, TX, USA, Proposal No 1R01HL160992-01A1): 2023-2027

Cardiac fibroblast inflammasome and atrial myopathy (supported by the National Institutes of Health, collaborative project with Baylor College of Medicine, Houston, TX, USA, Proposal No 1R01HL163277-01): 2022-2026

The role of Gasdermin-D/Interleukin-1 Nexus in atrial arrhythmogenesis (supported by the National Institutes of Health, collaborative project with Baylor College of Medicine, Houston, TX, USA, Proposal No 2R01HL136389-05): 2021-2026

Machine Learning and Artificial Intelligence for Early Detection of Stroke and Atrial Fibrillation, MAESTRIA (supported by The European Union, H2020 SC1-BHC-06-2020, large-scale integrating project, Proposal No. 965286): 2021-2026

Quantifying the Role of Cardiomyocyte Ultrastructure in Atrial Health and Disease (supported by National Institutes of Health, collaborative project with UC Davis, CA, USA, Proposal No. 2R01HL131517-06A1): 2021-2025

Repurposing of Mesna for cardioprotection in diabetes, supported by Single Project Grant of DFG, Proposal No. FE 1365/4-1): 2022-2024 

Ryanodine Receptor Regulation in Postoperative Atrial Fibrillation (supported by National Institutes of Health, collaborative project with Baylor College of Medicine, Houston, TX, USA, Proposal No. RO1 HL089598): 2019-2023

Previous research support (Selection)

Molecular Basis and Proarrhythmic Role of Enhanced Small-Conductance Ca²⁺-Activated K⁺ Channels in Patients with Atrial Fibrillation, (supported by Single Project Grant of DFG, Proposal No. DO 769/4-1): 2017-2022

The Role of Inflammasome in the Pathogenesis of Atrial Fibrillation (supported by National Institutes of Health, collaborative project with Baylor College of Medicine, Houston, TX, USA, Proposal No. RO1 HL136389-01): 2017-2022

Perturbed Sodium and Calcium Fluxes in Atrial Fibrillation (supported by National Institutes of Health, collaborative project with UC Davis, CA, USA, Proposal No. RO1 HL131517-01): 2016-2022

The European Network for Translational Research in Atrial Fibrillation, EUTRAF (supported by The European Union, FP7-HEALTH-2010, large-scale integrating project, Proposal No. 261057): 2010-2015

Molecular Mechanisms of Constitutively Active I_K,ACh in Patients with Atrial Fibrillation (supported by DFG, Proposal No. DO 769/1-1/3): 2008-2014

European-North American Atrial Fibrillation Research Alliance, ENAFRA (supported by The Transatlantic Networks of Excellence in Cardiovascular Research Program, Fondation Leducq, Network Grant No. 07CVD03): 2007-2013

German Centre for Cardiovascular Research ("Deutsches Zentrum für Herz-Kreislauf-Forschung", supported by BMBF, partner site Heidelberg/Mannheim: 2011-2013

Electrical Remodeling and Effects of Drugs in Human Chronic Atrial Fibrillation (supported by BMBF, Atrial Fibrillation Competence Network, AFNET, Proposal No. 01GI0204, Projects C3 and C4): 2003-2010